Canton, MI (September 10, 2012) - MMS Holdings Inc. announced today that they have added Dr. Greg Burkhart and Dr. Brent Blumenstein to its Data and Safety Monitoring Board (DSMB) leadership.
Dr. Burkhart is well known for his expertise with DSMBs and multiple data analyses formats as well as his experience in epidemiology. While serving on the MMS DSMB, he will work to provide sponsors with a seamless output across their programs and facilitate value-added discussions at the DSMB meetings.
Dr. Blumenstein brings 35 years of statistical experience along with expertise in agency preferences and best practices for our client’s portfolio’s. Drs. Burkhart and Blumenstein have worked together for many years and will bring to the MMS DSMB team their experiences and insights into current trends in the industry.
“Greg and Brent bring valuable leadership and expertise to our team.” Says Dr. Ethan Weiner, leader of DSMB efforts at MMS.
“Their experience will benefit clients and staff across many programs.”
For a brief biography of our newest DSMB leadership please go to: http://www.mmsholdings.com/clinical-leadership.htm.
MMS Holdings Inc. is a highly experienced pharmaceutical service organization, based in Canton Michigan, that is focused on quality deliverables in the areas of clinical programming, biostatistics, medical and regulatory writing, pharmacovigilance, clinical trial disclosure, data abstraction, and data management. Our DSMB serves several clients across therapeutic areas and we support all aspects of the DSMB including working with academic expertise. Commitment to quality deliverables with robust submission experience sets MMS apart from traditional service providers. MMS Holdings Inc. is ISO 9001:2008 certified for all services and maintains detailed quality metrics for every project.
For more information visit http://www.mmsholdings.com.